U.S. Research Launches Initiative to Help Treat Dementia


Applied Clinical Trials

The Synexus HealthyMinds Registry is seeking 30,000 U.S. participants, age 50 or older, who do not have dementia, for a five-year study examining the lifestyle and genetic risk factors impacting cognitive function over time. Supporting researchers’ goal of identifying ways to prevent and treat Alzheimer’s disease and other forms of dementia.  

Learn more about the initiative and how to participate here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.